This report aims to provide a comprehensive presentation of the global market for Prader-Willi Syndrome Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prader-Willi Syndrome Therapeutics. This report contains market size and forecasts of Prader-Willi Syndrome Therapeutics in global, including the following market information:
Global Prader-Willi Syndrome Therapeutics Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Prader-Willi Syndrome Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Beloranib Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prader-Willi Syndrome Therapeutics include Chong Kun Dang Pharmaceutical Corp., Essentialis, Inc., Ferring International Center S.A., LG Life Sciences, Ltd., P2D Bioscience, Pfizer Inc. and Rhythm Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prader-Willi Syndrome Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prader-Willi Syndrome Therapeutics Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Prader-Willi Syndrome Therapeutics Market Segment Percentages, by Type, 2022 (%)
Beloranib
Betahistine Hydrochloride
Diazoxide Choline CR
FE-992097
NOX-B11
Others
Global Prader-Willi Syndrome Therapeutics Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Prader-Willi Syndrome Therapeutics Market Segment Percentages, by Application, 2022 (%)
Clinic
Hospital
Others
Global Prader-Willi Syndrome Therapeutics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Prader-Willi Syndrome Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prader-Willi Syndrome Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prader-Willi Syndrome Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Chong Kun Dang Pharmaceutical Corp.
Essentialis, Inc.
Ferring International Center S.A.
LG Life Sciences, Ltd.
P2D Bioscience
Pfizer Inc.
Rhythm Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prader-Willi Syndrome Therapeutics, market overview.
Chapter 2: Global Prader-Willi Syndrome Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Prader-Willi Syndrome Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prader-Willi Syndrome Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prader-Willi Syndrome Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prader-Willi Syndrome Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prader-Willi Syndrome Therapeutics Overall Market Size
2.1 Global Prader-Willi Syndrome Therapeutics Market Size: 2022 VS 2030
2.2 Global Prader-Willi Syndrome Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prader-Willi Syndrome Therapeutics Players in Global Market
3.2 Top Global Prader-Willi Syndrome Therapeutics Companies Ranked by Revenue
3.3 Global Prader-Willi Syndrome Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Prader-Willi Syndrome Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prader-Willi Syndrome Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prader-Willi Syndrome Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Prader-Willi Syndrome Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Prader-Willi Syndrome Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prader-Willi Syndrome Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Beloranib
4.1.3 Betahistine Hydrochloride
4.1.4 Diazoxide Choline CR
4.1.5 FE-992097
4.1.6 NOX-B11
4.1.7 Others
4.2 By Type - Global Prader-Willi Syndrome Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Prader-Willi Syndrome Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Prader-Willi Syndrome Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global Prader-Willi Syndrome Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prader-Willi Syndrome Therapeutics Market Size, 2022 & 2030
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Prader-Willi Syndrome Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Prader-Willi Syndrome Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Prader-Willi Syndrome Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global Prader-Willi Syndrome Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Prader-Willi Syndrome Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Prader-Willi Syndrome Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Prader-Willi Syndrome Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Prader-Willi Syndrome Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global Prader-Willi Syndrome Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Prader-Willi Syndrome Therapeutics Revenue, 2018-2030
6.3.2 US Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.3.3 Canada Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.3.4 Mexico Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Prader-Willi Syndrome Therapeutics Revenue, 2018-2030
6.4.2 Germany Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.4.3 France Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.4.4 U.K. Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.4.5 Italy Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.4.6 Russia Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.4.8 Benelux Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Prader-Willi Syndrome Therapeutics Revenue, 2018-2030
6.5.2 China Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.5.3 Japan Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.5.4 South Korea Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.5.6 India Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Prader-Willi Syndrome Therapeutics Revenue, 2018-2030
6.6.2 Brazil Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.6.3 Argentina Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prader-Willi Syndrome Therapeutics Revenue, 2018-2030
6.7.2 Turkey Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.7.3 Israel Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
6.7.5 UAE Prader-Willi Syndrome Therapeutics Market Size, 2018-2030
7 Prader-Willi Syndrome Therapeutics Companies Profiles
7.1 Chong Kun Dang Pharmaceutical Corp.
7.1.1 Chong Kun Dang Pharmaceutical Corp. Company Summary
7.1.2 Chong Kun Dang Pharmaceutical Corp. Business Overview
7.1.3 Chong Kun Dang Pharmaceutical Corp. Prader-Willi Syndrome Therapeutics Major Product Offerings
7.1.4 Chong Kun Dang Pharmaceutical Corp. Prader-Willi Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Chong Kun Dang Pharmaceutical Corp. Key News & Latest Developments
7.2 Essentialis, Inc.
7.2.1 Essentialis, Inc. Company Summary
7.2.2 Essentialis, Inc. Business Overview
7.2.3 Essentialis, Inc. Prader-Willi Syndrome Therapeutics Major Product Offerings
7.2.4 Essentialis, Inc. Prader-Willi Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Essentialis, Inc. Key News & Latest Developments
7.3 Ferring International Center S.A.
7.3.1 Ferring International Center S.A. Company Summary
7.3.2 Ferring International Center S.A. Business Overview
7.3.3 Ferring International Center S.A. Prader-Willi Syndrome Therapeutics Major Product Offerings
7.3.4 Ferring International Center S.A. Prader-Willi Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Ferring International Center S.A. Key News & Latest Developments
7.4 LG Life Sciences, Ltd.
7.4.1 LG Life Sciences, Ltd. Company Summary
7.4.2 LG Life Sciences, Ltd. Business Overview
7.4.3 LG Life Sciences, Ltd. Prader-Willi Syndrome Therapeutics Major Product Offerings
7.4.4 LG Life Sciences, Ltd. Prader-Willi Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.4.5 LG Life Sciences, Ltd. Key News & Latest Developments
7.5 P2D Bioscience
7.5.1 P2D Bioscience Company Summary
7.5.2 P2D Bioscience Business Overview
7.5.3 P2D Bioscience Prader-Willi Syndrome Therapeutics Major Product Offerings
7.5.4 P2D Bioscience Prader-Willi Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.5.5 P2D Bioscience Key News & Latest Developments
7.6 Pfizer Inc.
7.6.1 Pfizer Inc. Company Summary
7.6.2 Pfizer Inc. Business Overview
7.6.3 Pfizer Inc. Prader-Willi Syndrome Therapeutics Major Product Offerings
7.6.4 Pfizer Inc. Prader-Willi Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Pfizer Inc. Key News & Latest Developments
7.7 Rhythm Pharmaceuticals
7.7.1 Rhythm Pharmaceuticals Company Summary
7.7.2 Rhythm Pharmaceuticals Business Overview
7.7.3 Rhythm Pharmaceuticals Prader-Willi Syndrome Therapeutics Major Product Offerings
7.7.4 Rhythm Pharmaceuticals Prader-Willi Syndrome Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Rhythm Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prader-Willi Syndrome Therapeutics Market Opportunities & Trends in Global Market
Table 2. Prader-Willi Syndrome Therapeutics Market Drivers in Global Market
Table 3. Prader-Willi Syndrome Therapeutics Market Restraints in Global Market
Table 4. Key Players of Prader-Willi Syndrome Therapeutics in Global Market
Table 5. Top Prader-Willi Syndrome Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prader-Willi Syndrome Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prader-Willi Syndrome Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prader-Willi Syndrome Therapeutics Product Type
Table 9. List of Global Tier 1 Prader-Willi Syndrome Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prader-Willi Syndrome Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Prader-Willi Syndrome Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prader-Willi Syndrome Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Prader-Willi Syndrome Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prader-Willi Syndrome Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Prader-Willi Syndrome Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prader-Willi Syndrome Therapeutics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2024-2030
Table 30. Chong Kun Dang Pharmaceutical Corp. Company Summary
Table 31. Chong Kun Dang Pharmaceutical Corp. Prader-Willi Syndrome Therapeutics Product Offerings
Table 32. Chong Kun Dang Pharmaceutical Corp. Prader-Willi Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Chong Kun Dang Pharmaceutical Corp. Key News & Latest Developments
Table 34. Essentialis, Inc. Company Summary
Table 35. Essentialis, Inc. Prader-Willi Syndrome Therapeutics Product Offerings
Table 36. Essentialis, Inc. Prader-Willi Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Essentialis, Inc. Key News & Latest Developments
Table 38. Ferring International Center S.A. Company Summary
Table 39. Ferring International Center S.A. Prader-Willi Syndrome Therapeutics Product Offerings
Table 40. Ferring International Center S.A. Prader-Willi Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Ferring International Center S.A. Key News & Latest Developments
Table 42. LG Life Sciences, Ltd. Company Summary
Table 43. LG Life Sciences, Ltd. Prader-Willi Syndrome Therapeutics Product Offerings
Table 44. LG Life Sciences, Ltd. Prader-Willi Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. LG Life Sciences, Ltd. Key News & Latest Developments
Table 46. P2D Bioscience Company Summary
Table 47. P2D Bioscience Prader-Willi Syndrome Therapeutics Product Offerings
Table 48. P2D Bioscience Prader-Willi Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. P2D Bioscience Key News & Latest Developments
Table 50. Pfizer Inc. Company Summary
Table 51. Pfizer Inc. Prader-Willi Syndrome Therapeutics Product Offerings
Table 52. Pfizer Inc. Prader-Willi Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Pfizer Inc. Key News & Latest Developments
Table 54. Rhythm Pharmaceuticals Company Summary
Table 55. Rhythm Pharmaceuticals Prader-Willi Syndrome Therapeutics Product Offerings
Table 56. Rhythm Pharmaceuticals Prader-Willi Syndrome Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Rhythm Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Prader-Willi Syndrome Therapeutics Segment by Type in 2022
Figure 2. Prader-Willi Syndrome Therapeutics Segment by Application in 2022
Figure 3. Global Prader-Willi Syndrome Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prader-Willi Syndrome Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Prader-Willi Syndrome Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prader-Willi Syndrome Therapeutics Revenue in 2022
Figure 8. By Type - Global Prader-Willi Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Prader-Willi Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Prader-Willi Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Prader-Willi Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Prader-Willi Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Prader-Willi Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 16. US Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Prader-Willi Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 20. Germany Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 21. France Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Prader-Willi Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 28. China Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 32. India Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Prader-Willi Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 34. Brazil Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Prader-Willi Syndrome Therapeutics Revenue Market Share, 2018-2030
Figure 37. Turkey Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Prader-Willi Syndrome Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 41. Chong Kun Dang Pharmaceutical Corp. Prader-Willi Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Essentialis, Inc. Prader-Willi Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Ferring International Center S.A. Prader-Willi Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. LG Life Sciences, Ltd. Prader-Willi Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. P2D Bioscience Prader-Willi Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer Inc. Prader-Willi Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Rhythm Pharmaceuticals Prader-Willi Syndrome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
